ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PSNL vs CLOV // FREE CASH FLOW YIELD

Personalis Inc. (NASDAQ) VS. Clover Health Investments Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: PSNL 1 — CLOV 7
▲ FREE CASH FLOW YIELD LEADER: CLOV
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PSNL VS. CLOV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PSNL CLOV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 22.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -29.30% -5.70 CLOV /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -4.67% -2.84% -1.83 CLOV /fcf-yield <GO>
Operating Margin -60.00% -4.40% -55.60 CLOV /operating-margins <GO>
Net Profit Margin -60.00% -4.40% -55.60 CLOV /net-margins <GO>
Revenue Growth (YoY) -17.70% 40.30% -58.00 CLOV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.50 3.62 +7.88 PSNL /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.2 45.3 -0.06 CLOV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.70B $2.43B -$731.9M CLOV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PSNL REV CLOV REV PSNL GROSS % CLOV GROSS % PSNL FCF CLOV FCF
FY 2025 $69.6M $1.92B 22.7% — -$79.5M -$69.0M
FY 2024 $84.6M $1.37B 31.7% — -$46.8M $33.3M
FY 2023 $73.5M $1.26B — — -$56.3M -$144.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PSNL // BETA —
CLOV // BETA —